These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

522 related items for PubMed ID: 25373125

  • 1. Acute and long-term behavioral outcome of infants and children exposed in utero to either maternal depression or antidepressants: a review of the literature.
    Suri R, Lin AS, Cohen LS, Altshuler LL.
    J Clin Psychiatry; 2014 Oct; 75(10):e1142-52. PubMed ID: 25373125
    [Abstract] [Full Text] [Related]

  • 2. [Current evaluation of teratogenic and fetotoxic effects of psychotropic drugs].
    Watanabe O.
    Seishin Shinkeigaku Zasshi; 2014 Oct; 116(12):996-1004. PubMed ID: 25823351
    [Abstract] [Full Text] [Related]

  • 3. Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study.
    Nulman I, Rovet J, Stewart DE, Wolpin J, Pace-Asciak P, Shuhaiber S, Koren G.
    Am J Psychiatry; 2002 Nov; 159(11):1889-95. PubMed ID: 12411224
    [Abstract] [Full Text] [Related]

  • 4. Neonatal growth outcomes at birth and one month postpartum following in utero exposure to antidepressant medication.
    Lewis AJ, Galbally M, Opie G, Buist A.
    Aust N Z J Psychiatry; 2010 May; 44(5):482-7. PubMed ID: 20397792
    [Abstract] [Full Text] [Related]

  • 5. Prenatal antidepressant exposure and behavioral problems in early childhood--a cohort study.
    Pedersen LH, Henriksen TB, Bech BH, Licht RW, Kjaer D, Olsen J.
    Acta Psychiatr Scand; 2013 Feb; 127(2):126-35. PubMed ID: 23126521
    [Abstract] [Full Text] [Related]

  • 6. Neonatal outcome following pregnancy exposure to antidepressants: a prospective controlled cohort study.
    Maschi S, Clavenna A, Campi R, Schiavetti B, Bernat M, Bonati M.
    BJOG; 2008 Jan; 115(2):283-9. PubMed ID: 17903222
    [Abstract] [Full Text] [Related]

  • 7. Prenatal exposure to antidepressant medications and neurodevelopmental outcomes: a systematic review.
    Gentile S, Galbally M.
    J Affect Disord; 2011 Jan; 128(1-2):1-9. PubMed ID: 20303599
    [Abstract] [Full Text] [Related]

  • 8. Pharmacologic treatment of depression during pregnancy.
    Wisner KL, Gelenberg AJ, Leonard H, Zarin D, Frank E.
    JAMA; 1999 Oct 06; 282(13):1264-9. PubMed ID: 10517430
    [Abstract] [Full Text] [Related]

  • 9. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
    Singal D, Brownell M, Chateau D, Ruth C, Katz LY.
    BMJ Open; 2016 Nov 29; 6(11):e013293. PubMed ID: 27899401
    [Abstract] [Full Text] [Related]

  • 10. Controversies about the use of antidepressants in pregnancy.
    Robinson GE.
    J Nerv Ment Dis; 2015 Mar 29; 203(3):159-63. PubMed ID: 25714252
    [Abstract] [Full Text] [Related]

  • 11. Placental and fetal effects of antenatal exposure to antidepressants or untreated maternal depression.
    Gentile S, Fusco ML.
    J Matern Fetal Neonatal Med; 2017 May 29; 30(10):1189-1199. PubMed ID: 27379818
    [Abstract] [Full Text] [Related]

  • 12. Use of antidepressant medication in pregnancy and adverse neonatal outcomes: A population-based investigation.
    Cantarutti A, Merlino L, Giaquinto C, Corrao G.
    Pharmacoepidemiol Drug Saf; 2017 Sep 29; 26(9):1100-1108. PubMed ID: 28594145
    [Abstract] [Full Text] [Related]

  • 13. Antidepressant use in pregnancy: an evaluation of adverse outcomes excluding malformation.
    Lorenzo L, Einarson A.
    Isr J Psychiatry Relat Sci; 2014 Sep 29; 51(2):94-104. PubMed ID: 25372558
    [Abstract] [Full Text] [Related]

  • 14. Developmental outcomes of children exposed to antidepressants in pregnancy.
    Galbally M, Lewis AJ, Buist A.
    Aust N Z J Psychiatry; 2011 May 29; 45(5):393-9. PubMed ID: 21314237
    [Abstract] [Full Text] [Related]

  • 15. Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis.
    Ross LE, Grigoriadis S, Mamisashvili L, Vonderporten EH, Roerecke M, Rehm J, Dennis CL, Koren G, Steiner M, Mousmanis P, Cheung A.
    JAMA Psychiatry; 2013 Apr 29; 70(4):436-43. PubMed ID: 23446732
    [Abstract] [Full Text] [Related]

  • 16. Long-Term Effects of Intrauterine Exposure to Antidepressants on Physical, Neurodevelopmental, and Psychiatric Outcomes: A Systematic Review.
    Rommel AS, Bergink V, Liu X, Munk-Olsen T, Molenaar NM.
    J Clin Psychiatry; 2020 May 12; 81(3):. PubMed ID: 32412703
    [Abstract] [Full Text] [Related]

  • 17. Antidepressant Treatment of Depression During Pregnancy and the Postpartum Period.
    McDonagh M, Matthews A, Phillipi C, Romm J, Peterson K, Thakurta S, Guise JM.
    Evid Rep Technol Assess (Full Rep); 2014 Jul 12; (216):1-308. PubMed ID: 30313002
    [Abstract] [Full Text] [Related]

  • 18. Neurodevelopmental effects of prenatal exposure to psychotropic medications.
    Gentile S.
    Depress Anxiety; 2010 Jul 12; 27(7):675-86. PubMed ID: 20583298
    [Abstract] [Full Text] [Related]

  • 19. Managing unipolar depression in pregnancy.
    Raudzus J, Misri S.
    Curr Opin Psychiatry; 2009 Jan 12; 22(1):13-8. PubMed ID: 19122529
    [Abstract] [Full Text] [Related]

  • 20. Neurobehavioral assessment of infants born at term and in utero exposure to serotonin reuptake inhibitors.
    Smith MV, Sung A, Shah B, Mayes L, Klein DS, Yonkers KA.
    Early Hum Dev; 2013 Feb 12; 89(2):81-6. PubMed ID: 22999988
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.